| 90 article results |
|
-
Contributor: Helen Winsor
Posted: 09/08/2010 12:00:00 AM EDT | 0
Reto Ossola, Group Leader for Biomarker Research at Biognosys, joins Pharma IQ to discuss the main challenges in biomarker development and some key ways to address these. Ossola offers some best p... Read more
-
Contributor: Pharma IQ
Posted: 09/08/2010 12:00:00 AM EDT | 0
Counterfeit medicines present a serious challenge for the pharmaceutical industry. As well as the dangers to public health presented by such drugs, the presence of counterfeit medicines serves to reduce confidence within the pharmaceutical industry as a whole. Ensurin... Read more
-
Contributor: Dato’ Dr. Zaininah Mohd Zain
Posted: 09/06/2010 12:00:00 AM EDT | 0
Disasters and infectious disease outbreaks over the last several years have demonstrated the importance of emergency preparedness for large-scale events affecting many people. The ability to respond effectively to events producing a massive influx of patients that disrupt daily operat... Read more
-
Contributor: Pharma IQ
Posted: 09/06/2010 12:00:00 AM EDT | 0
Good manufacturing process (GMP) guidelines are essential to ensure drugs are produced to a consistently high quality. GMP guidelines should be implemented at all stages of the manufacturing process to eliminate the possibility of risks, that may not be detected during clinical trials... Read more
-
Contributor: Helen Winsor
Posted: 09/06/2010 12:00:00 AM EDT | 0
Amorphous pharmaceutical materials are now being recognised as an attractive alternative route for solid state development. Dr. Dave Miller, Senior Principal Scientist at Hoffmann-La Roche, sp... Read more
-
Contributor: Pharma IQ
Posted: 09/03/2010 12:00:00 AM EDT | 0
If the trends that have been seen in the pharmaceutical industry over the past few years prove anything, it is that drug development companies are increasingly recognising the value of teamwork. There is plenty of evidence that businesses in the sector are seeing the benefits that par... Read more
-
Contributor: Joseph Kofman
Posted: 09/02/2010 12:00:00 AM EDT | 0
Pharma IQ Q&A: An interview with Joseph Kofman, PhD, R&D Information Systems Director, Allergan, on exploring and adopting... Read more
-
Contributor: Pharma IQ
Posted: 09/01/2010 12:00:00 AM EDT | 1
Growth in the pharmaceutical industry means that the worldwide cold chain industry is expected to be worth $6.6 billion (£4.2 billion) by the year 2011. The Middle East and North Africa (MENA) region has played a large part in this growth and pharmaceutical indu... Read more
-
Contributor: Pharma IQ
Posted: 09/01/2010 12:00:00 AM EDT | 0
Pharma regulatory affairs professionals play an essential role in ensuring all pharmaceutical products comply with regulations governing the industry. Those working in pharma regulatory affairs jobs not only work in the initial application phase for a new or generic drug,... Read more
-
Contributor: Pharma IQ
Posted: 09/01/2010 12:00:00 AM EDT | 0
An ageing population and the increasing number of conditions becoming treatable, means that efficient hospital management is essential to ensure patients are provided with timely and appropriate care. Taking Australia as an example, a recent study by Ian Scott, direct... Read more
| 90 article results |
|
-
Genotoxicity & Carcinogenicity Testing 2010
Le Meridien Piccadilly, London
October 18- 20, 2010 -
Clinical Evaluations and Investigations for Medical Devices
Andel’s Hotel, Berlin, Germany
October 18- 20, 2010 -
3rd Annual Disposable Solutions for Biomanufacturing
Venue to be Confirmed, Brussels
January 30- 2, 2011 -
BioPatent Design
Hilton Munich Park, Munich, Germany
September 7- 9, 2010
-
Improving Hospital Efficiency Through Technology
hospital efficiency | medical devices | medical device management
-
Biopharmaceutical Cold Chain: Investing in the MENA Region
cold chain MENA | MENA region | Middle East and North Africa
-
Evaluating Biomarkers for Cancer Screening
Stuart Baker | Barnett Kramer | biomarkers


